diseases earlier, treat them or prevent them altogether through preventive action," emphasises Professor Dr. Michael P. Manns, President of Hannover Medical School (MHH), who co-chaired the Liver Commission [...] most liver diseases is possible today thanks to significant achievements in modern medicine," says Professor Manns. The hepatitis B vaccine, for example, is the first vaccine proven to prevent cancer. In addition [...] things, research in the field of liver diseases. SERVICE: For further information , please contact Professor Dr. Michael P. Manns, manns.michael@mh-hannover.de , telephone (0511) 532-6001. The original paper

"This is an outstanding success for the promotion of young scientists at MHH," says MHH President Professor Dr. Michael Manns. "Laura Hinze is an exceptional talent. Actually, she was still too young to take [...] followed. She has been a doctor since December 2020 and has been working as a doctor and scientist in Professor Dr Christian Kratz's paediatric oncology clinic since 1 January 2021. Now she receives the award [...] Laura Hinze, hinze.laura@mh-hannover.de , phone (0511) 532-7880. A video in which MHH President Professor Dr. Michael Manns visits Dr. Laura Hinze's laboratory and talks to her about her research can be

. However, it can be revived with the body's own substance spermidine. A research group led by Professor Dr. Evgeni Ponimaskin from the Institute of Neurophysiology at the Hannover Medical School (MHH) [...] administration affects organs commonly affected by age and the pathway by which this occurs," explains Professor Ponimaskin. The research group of neurophysiologists, nuclear medicine specialists and molecular [...] telomeres in the spermidine-supplemented mice were similar in length to those in young animals," says Professor Ponimaskin. Since the ageing processes in the cells of mice are similar to those in our body cells

– this is the ambitious goal of scientists at Hannover Medical School (MHH). With this in mind, Professor Dr. Nico Lachmann and Dr. Robert Zweigerdt have initiated a research collaboration and license agreement [...] study. So far, there has been no clinical application of iPS cell progenies in Germany," explains Professor Lachmann. Macrophages as a therapeutic agent for bacterial lung infections In pre-clinical proo [...] am very pleased that we can now advance this idea towards real therapies," says Dr. Zweigerdt. Professor Lachmann holds a professorship funded by the Cluster of Excellence RESIST and conducts research

Biotechnology and Artificial Organs (LEBAO) at the Hannover Medical School (MHH) and LEBAO director Professor Dr. Ulrich Martin, now want to develop a new therapy in which damaged tissue areas can be repaired [...] tissue and improve organ function in animal models as part of the iCARE project coordinated by Professor Martin. In the new research project HEAL, the strategies for producing and administering the iPS [...] gene into the iPS cells that can be activated if the applied cells degenerate in the body," says Professor Martin. "In the end, we want to produce safe cell products that can also be produced on a large

first time, we have an approach to combat the virus directly without major side effects," explains Professor Dr Thomas Skripuletz, senior physician at the MHH Department of Neurology. The solution lies in [...] cells are HLA-compatible, i.e. have the same tissue characteristics as the recipients," explains Professor Dr. Britta Eiz-Vesper, immunologist at the MHH Institute for Transfusion Medicine and Transplant [...] means we are well on our way from a non-treatable disease to a successful PML therapy," emphasises Professor Skripuletz. This is all the more important, he says, as the disease is probably too seldom in the

scientist, represents the special role that science has to play during the COVID 19 pandemic - Professor Dr Christian Drosten, Director of the Institute of Virology at the Charité Mitte Campus of the [...] infections) will continue to pose major challenges to globalised society in the coming decades. Professor Drosten already established a research programme for the diagnosis of tropical viral diseases at

research with their treatment data. "Help develop the medicine of tomorrow!", asks MHH President Professor Dr. Michael Manns. The MHH is part of the Medical Informatics Initiative (MII) of the Federal Ministry [...] university hospitals are participating, we are jointly advocating medical progress," emphasises Professor Manns. The patient data will be made available to researchers at other German university hospitals

diagnosed and receive the best possible therapy depending on the individual tumor situation," says Professor Dr. Mohamed Omar, medical director of the Sarcoma Center and division head of musculoskeletal tumor [...] pelvis or when conventional tumor endoprostheses are not suitable for reconstruction," explains Professor Omar. "Using 3D technology, we can have precisely fitting implants made, which we insert into the [...] will initially be awarded to the center until May 2023. SERVICE: For more information , contact Professor Mohamed Omar, MD, omar.mohamed@mh-hannover.de , www.mhh.de/sarkomzentrum DKG-certified centers at

y and Professor Dr. Christian Könecke from the Department of Haematology, Haemostaseology, Oncology and Stem Cell Transplantation at Hannover Medical School (MHH), in cooperation with Professor Dr. Immo [...] as early as two weeks after treatment as to whether the leukaemia is returning or not," explains Professor Könecke. These changes were already detected in the study 11 months before the clinical diagnosis